Biotech: Social Justice Matters

By: Steven Holtzman, President and CEO, Decibel Therapeutics Inc.
Trump’s ban on immigration and the notion of a religious test are deeply repugnant to the fundamental tenets and values of not only the United States but also the biotechnology industry. We are a science-based enterprise built on the belief...
Read More

Leadership and Responsibility

By: Steven Holtzman, President and CEO, Decibel Therapeutics Inc.
In the presidential election, a significant proportion of American voters, feeling unspoken for and left behind by establishment politicians and policies, expressed their displeasure and desire for change. The campaign also gave voice to disturbing currents of thought -- a...
Read More

Children’s Headphones May Carry Risk of Hearing Loss

By: Catherine Saint Louis
We're seeing more and more reported incidents of hearing loss caused by listening to excessively loud music, and the damage is increasingly starting at a younger age. There are a number of safe listening claims among headphone brands, but a...
Read More

6 THINGS YOUR EARS ARE TRYING TO TELL YOU

By: Nicole Frehsee
The link between hearing and health cannot be understated, and the importance of being proactive in addressing any hearing impairments over time is imperative to social, psychological and cognitive health. Hearing loss is not an ailment of old age, nor...
Read More

On NPV, DCF and IRR(elevance)?

By: Steven Holtzman, President and CEO, Decibel Therapeutics Inc.
Confronted with the business imperative and opportunity to in-license or acquire a late-stage clinical product candidate, biopharmaceutical leadership teams immediately turn to financial analysis tools to evaluate the asset. No doubt NPV, DCF and other financial analyses have a role...
Read More